These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27814442)

  • 41. Botulinum toxin in the treatment of sialorrhea.
    Svetel M; Vasić M; Dragasević N; Pekmezović T; Petrović I; Kostić V
    Vojnosanit Pregl; 2009 Jan; 66(1):9-12. PubMed ID: 19195257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ultrasound-guided injection of botulinum toxin A into the submandibular gland in children and young adults with sialorrhoea.
    Gok G; Cox N; Bajwa J; Christodoulou D; Moody A; Howlett DC
    Br J Oral Maxillofac Surg; 2013 Apr; 51(3):231-3. PubMed ID: 22939893
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin type-A (Botox-A) injections for treatment of sialorrhoea in adults: a New Zealand study.
    Shetty S; Dawes P; Ruske D; Al-qudah M; Lyons B
    N Z Med J; 2006 Aug; 119(1240):U2129. PubMed ID: 16924280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Controlling sialorrhoea: a review of available treatment options.
    Potulska A; Friedman A
    Expert Opin Pharmacother; 2005 Aug; 6(9):1551-4. PubMed ID: 16086642
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Managing children with sialorrhoea (drooling): Experience from the first 301 children in our saliva control clinic.
    Montgomery J; McCusker S; Lang K; Grosse S; Mace A; Lumley R; Kubba H
    Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():33-9. PubMed ID: 27240493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of oral secretions in neurological disease.
    McGeachan AJ; Mcdermott CJ
    Pract Neurol; 2017 Apr; 17(2):96-103. PubMed ID: 28188210
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations.
    Tan EK
    Eur J Neurol; 2006 Feb; 13 Suppl 1():60-4. PubMed ID: 16417600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term follow-up of ultrasound-guided botulinum toxin-A injections for sialorrhea in neurological dysphagia.
    Barbero P; Busso M; Tinivella M; Artusi CA; De Mercanti S; Cucci A; Veltri A; Avagnina P; Calvo A; Chio' A; Durelli L; Clerico M
    J Neurol; 2015 Dec; 262(12):2662-7. PubMed ID: 26410746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.
    Reid SM; Johnstone BR; Westbury C; Rawicki B; Reddihough DS
    Dev Med Child Neurol; 2008 Feb; 50(2):123-8. PubMed ID: 18201301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. US-guided botulinum toxin injection for excessive drooling in children.
    Çiftçi T; Akıncı D; Yurttutan N; Akhan O
    Diagn Interv Radiol; 2013; 19(1):56-60. PubMed ID: 22798155
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study.
    Hay N; Penn C
    Int J Lang Commun Disord; 2011; 46(5):550-63. PubMed ID: 21899672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin-A injections vs radiotherapy for drooling in ALS.
    Weikamp JG; Schinagl DA; Verstappen CC; Schelhaas HJ; de Swart BJ; Kalf JG
    Acta Neurol Scand; 2016 Sep; 134(3):224-31. PubMed ID: 26803950
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of botulinum toxic injection to treat excessive drooling in children with neurological conditions.
    Khan A; Pawar G
    W V Med J; 2005; 101(6):258-60. PubMed ID: 16625812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful management of drooling with botulinum toxin A in neurologically disabled children.
    Ellies M; Rohrbach-Volland S; Arglebe C; Wilken B; Laskawi R; Hanefeld F
    Neuropediatrics; 2002 Dec; 33(6):327-30. PubMed ID: 12571790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of drooling: 10 years after the Consortium on Drooling 1990.
    Berweck S; Schwerin A; Heinen F
    Dev Med Child Neurol; 2003 Dec; 45(12):845; author reply 845-6. PubMed ID: 14667080
    [No Abstract]   [Full Text] [Related]  

  • 56. Botulinum toxin in the treatment of sialorrhea in severe neurological patients with tracheotomy.
    Shao M; Chen K; Wu X; Lin J; Jiang M; Zhuo F; Ying Z; Huang Y
    Brain Behav; 2023 Aug; 13(8):e3164. PubMed ID: 37461166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgical management of chronic sialorrhea in pediatric patients: 10-year experience from one tertiary care institution.
    Formeister EJ; Dahl JP; Rose AS
    Int J Pediatr Otorhinolaryngol; 2014 Aug; 78(8):1387-92. PubMed ID: 24974144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ultrasound-guided botulinum toxin A injection: an alternative treatment for dribbling.
    Marina MB; Sani A; Hamzaini AH; Hamidon BB
    J Laryngol Otol; 2008 Jun; 122(6):609-14. PubMed ID: 17640435
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
    Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Botulinum toxin A after microvascular ALT flap in a patient with (corrected) squamous cell carcinoma of the tongue].
    Ihler F; Laskawi R; Matthias C; Rustenbeck HH; Canis M
    HNO; 2012 Jun; 60(6):524-7. PubMed ID: 22534678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.